Rocket Lab (NASDAQ:RKLB) Stock Price Target Lowered at Citizens Jmp

Posted by Geri Gentry on Oct 16th, 2026

Rocket Lab (NASDAQ:RKLB – Get Free Report) had its target price reduced by equities research analysts at Citizens Jmp from $130.00 to $90.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “market outperform” rating on the rocket manufacturer’s stock. Citizens Jmp’s price objective would suggest a potential upside of 62.90% from the stock’s previous close.

Several other equities research analysts have also recently issued reports on the company. Bank of America reduced their target price on Rocket Lab from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, August 31st. KeyCorp dropped their price target on Rocket Lab from $135.00 to $100.00 and set an “overweight” rating for the company in a research note on Thursday. Barclays began coverage on Rocket Lab in a research note on Friday, October 9th. They issued an “overweight” rating and a $85.00 price objective on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a research report on Thursday. Finally, Craig Hallum lifted their price objective on shares of Rocket Lab from $98.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, June 29th. Three equities research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Rocket Lab presently has an average rating of “Moderate Buy” and a consensus price target of $102.05.

Read Our Latest Report on RKLB

Rocket Lab Price Performance

Shares of Rocket Lab stock opened at $55.25 on Friday. The company has a market capitalization of $33.06 billion, a price-to-earnings ratio of -204.62 and a beta of 2.93. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The stock’s 50-day simple moving average is $69.50 and its 200-day simple moving average is $84.29. Rocket Lab has a 52 week low of $37.57 and a 52 week high of $151.00.

Rocket Lab (NASDAQ:RKLB – Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The company had revenue of $234.07 million for the quarter, compared to analysts’ expectations of $231.62 million. Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. As a group, analysts expect that Rocket Lab will post -0.20 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Rocket Lab news, SVP Arjun Kampani sold 6,034 shares of the firm’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $66.65, for a total transaction of $402,166.10. Following the transaction, the senior vice president directly owned 250,917 shares in the company, valued at $16,723,618.05. This trade represents a 2.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Marvin Clevenger sold 15,051 shares of Rocket Lab stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $1,048,001.13. Following the sale, the insider directly owned 458,924 shares of the company’s stock, valued at approximately $31,954,878.12. This trade represents a 3.18% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 400,749 shares of company stock worth $26,964,474 over the last 90 days. Corporate insiders own 8.40% of the company’s stock.

Institutional Trading of Rocket Lab

Institutional investors and hedge funds have recently made changes to their positions in the company. TB Alternative Assets Ltd. lifted its stake in Rocket Lab by 508.5% in the third quarter. TB Alternative Assets Ltd. now owns 320,703 shares of the rocket manufacturer’s stock worth $22,347,000 after acquiring an additional 268,000 shares during the period. Cornerstone Enterprises LLC grew its holdings in Rocket Lab by 74.4% during the 3rd quarter. Cornerstone Enterprises LLC now owns 6,122 shares of the rocket manufacturer’s stock worth $427,000 after acquiring an additional 2,611 shares in the last quarter. NFSG Corp increased its position in Rocket Lab by 315.0% during the 3rd quarter. NFSG Corp now owns 10,841 shares of the rocket manufacturer’s stock valued at $755,000 after purchasing an additional 8,229 shares during the period. V Square Quantitative Management LLC increased its position in Rocket Lab by 207.4% during the 3rd quarter. V Square Quantitative Management LLC now owns 2,327 shares of the rocket manufacturer’s stock valued at $162,000 after purchasing an additional 1,570 shares during the period. Finally, YANKCOM Partnership purchased a new position in Rocket Lab during the 3rd quarter valued at about $73,000. 71.78% of the stock is currently owned by institutional investors.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

Positive Sentiment: Rocket Lab reported record second-quarter revenue of approximately $234 million, up 62% year over year, supported by its Electron launch business, satellite operations and defense-related contracts. The company also reportedly has a backlog of about $2.4 billion. Rocket Lab Still Has a $2.4B Backlog While Neutron Waits
Positive Sentiment: Several analysts remained constructive despite the setback. TD Cowen reaffirmed a Buy rating with a $90 price target, while Roth Capital maintained a Buy rating and a $110 target. These targets imply significant potential upside from recent levels. Stay Cool, Says Analyst About Rocket Lab Stock
Neutral Sentiment: Rocket Lab’s broader business remains active, including Electron and HASTE launches, spacecraft components and government and defense programs. However, investors are increasingly focused on whether the company can execute its longer-term growth strategy while Neutron development continues.
Negative Sentiment: Rocket Lab moved Neutron’s inaugural launch to 2027 from its prior fourth-quarter 2026 target. The delay followed a manufacturing flaw in a carbon-composite propellant-tank dome; the company plans additional repairs and testing before setting a launch date. Neutron is strategically important because management’s path to positive adjusted EBITDA depends heavily on the program’s progress. Rocket Lab pushes Neutron rocket’s debut flight to 2027, shares fall
Negative Sentiment: The setback heightened concerns about execution risk, cash burn and competition with SpaceX. KeyBanc and Clear Street reportedly reduced their price targets, while prior equity issuance to help fund the Iridium acquisition and continued insider selling added to the stock’s overhang. RKLB Stock Alert: What to Know as Rocket Lab Announces Neutron Launch Delay

Rocket Lab Company Profile

(Get Free Report)

Rocket Lab USA, Inc is a space and launch company that provides launch services, spacecraft, satellite components and other space systems for commercial, civil and national-security customers. The company designs and manufactures many of its products in-house, supporting missions from initial spacecraft development through launch and on-orbit operations.

Rocket Lab’s primary launch vehicle is Electron, a small-lift rocket designed to place satellites into low Earth orbit. The company also operates the HASTE suborbital test platform for hypersonic and other advanced aerospace technologies and is developing Neutron, a larger reusable rocket intended to serve commercial and government missions.